Low-cost wearable sensors may lead to better Parkinson’s care
By
John O'Connor
Apr 17, 2024
For those with Parkinson’s disease, low-cost, wearable sensors could improve care access, a new study finds. To have their symptoms monitored, such patients must periodically undergo assessment to have...
Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease
Apr 11, 2024
The infusion increases on time without troublesome dyskinesia and reduces daily off time.
Lixisenatide reduces motor disability progression in Parkinson’s disease
Apr 04, 2024
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
Let there be light! Eye-phototherapy device for Parkinson’s is released after long development delay
By
Aaron Dorman
Apr 01, 2024
A light-therapy device for Parkinson’s that has been in the works since before the pandemic is now ready for a new trial, developers said.
Get Grandma on TikTok: AI can use video to help expedite Parkinson’s diagnosis
By
Aaron Dorman
Mar 29, 2024
AI systems can evaluate video of people walking to diagnose Parkinson’s disease in less than 30 minutes, researchers said.
Electrically exciting the brain … and new therapy tools for Alzheimer’s and Parkinson’s?
By
Aaron Dorman
Mar 22, 2024
New research using an electric current caused brain activity to shift, a breakthrough for treating Alzheimer’s or Parkinson’s.
AAN: Three pesticides linked to risk for Parkinson’s disease
Mar 11, 2024
The highest versus lowest decile of application of simazine, lindane atrazine were linked to increased relative risks for Parkinson’s disease.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
Digital ‘communication bridge’ for seniors with aphasia is $13M closer to reality
By
Aaron Dorman
Mar 05, 2024
An upcoming research program will examine the potential for telehealth and wearable sensors to address a specific primary progressive aphasia.
Deep brain stimulation map of ‘dysfunctome’ could benefit people living with Parkinson’s, study...
By
Aaron Dorman
Feb 28, 2024
Researchers used DBS to create a “human dysfunctome,” a map of the brain’s frontal cortex, and study four diseases including Parkinson’s.